Position in GOSS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$2,895
-$2,878 QoQ
Shares Held
17,550
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#129
of 168 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DRIVE WEALTH MANAGEMENT, LLC holds $2,015,581 across 6 Biotechnology names. GOSS ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,919 | $953,224 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
2,773 | $317,979 | |
| 3 | CYTK |
Cytokinetics Inc
|
2,990 | $254,717 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
7,085 | $250,737 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,338 | $236,029 | |
| 6 | GOSS |
Gossamer Bio, Inc.
This page
|
17,550 | $2,895 |
All Filings in GOSS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,895 | 17,550 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $5,773 | 17,550 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $66,092 | 21,320 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $47,866 | 18,200 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $31,333 | 25,474 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $18,344 | 16,677 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||